Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review)

By        

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 639-648

Spandidos Publications

Access to resources Recommend Favorite

Pulsed reduced dose-rate radiotherapy: case report: A novel re-treatment strategy in the management of recurrent glioblastoma multiforme

By Cannon George   Tomé Wolfgang   Robins H.   Howard Steven  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 307-311

Springer Publishing Company

Access to resources Recommend Favorite

Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme

By Baumann Fabian   Bjeljac Miroslava   Kollias Spyros   Baumert Brigitta   Brandner Sebastian   Rousson Valentin   Yonekawa Yasuhiro   Bernays René  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets

By Mao Hua   LeBrun Drake G.   Yang Jingxuan   Zhu Vivian F.   Li Min  

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 48-56

Informa Healthcare

Access to resources Recommend Favorite

Translational research in glioblastoma multiforme: molecular criteria for patient selection

By Rosell Rafael   de las Peññas Ramon   Balañña Carme   Santarpia Mariacarmela   Salazar Fernanda   de Aguirre Itziar   Reguart Noemi   Villa Salvador   Wei Jia   Ramirez Jose Luis   Molina Miguel Angel   Ramon y Cajal Santiago   Jablons David   Taron Miquel  

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 219-228

Future Medicine

Access to resources Recommend Favorite